Evidence map›Paper›PMID 24910074›Full record

ArticleNeuropharmacology2014

The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.

Darren R Quelch, Sarah L Withey, David J Nutt, Robin J Tyacke, Christine A Parker

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  5. Article
  6. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Darren R QuelchCentre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK. Electronic address: d.quelch09@imperial.ac.uk.
Sarah L WitheySchool of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TD, UK.
David J NuttCentre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
Robin J TyackeCentre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
Christine A ParkerCentre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK; Global Imaging Unit, GlaxoSmithKline, UK.
Imperial College London · GBUniversity of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H53072X/1Medical Research Council G1002226
6 · The paper itself

Abstract

Various D2/3 receptor PET radioligands are sensitive to endogenous dopamine release in vivo. The Occupancy Model is generally used to interpret changes in binding observed in in vivo competition binding studies; an Internalisation Hypothesis may also contribute to these changes in signal. Extension of in vivo competition imaging to other receptor systems has been relatively unsuccessful. A greater understanding of the cellular processes underlying signal changes following endogenous neurotransmitter release may help translate this imaging paradigm to other receptor systems. To investigate the Internalisation Hypothesis we assessed the effects of different cellular environments, representative of those experienced by a receptor following agonist-induced internalisation, on the binding of three D2/3 PET ligands with previously reported sensitivities to endogenous dopamine in vivo, namely [3H]spiperone, [3H]raclopride and [3H]PhNO. Furthermore, we determined the contribution of each cellular compartment to total striatal binding for these D2/3 ligands. These studies suggest that sensitivity to endogenous dopamine release in vivo is related to a decrease in affinity in the endosomal environment compared with those found at the cell surface. In agreement with these findings we also demonstrate that ∼25% of total striatal binding for [3H]spiperone originates from sub-cellular, microsomal receptors, whereas for [3H]raclopride and [3H]PhNO, this fraction is lower, representing ∼14% and 17%, respectively. This pharmacological approach is fully translatable to other receptor systems. Assessment of affinity shifts in different cellular compartments may play a crucial role for understanding if a radioligand is sensitive to endogenous release in vivo, for not just the D2/3, but other receptor systems.

Indexed as

AnimalsCell MembraneCorpus StriatumDopamine D2 Receptor AntagonistsEndosomesExtracellular SpaceKineticsMalePositron-Emission TomographyRacloprideRadioligand AssayRadiopharmaceuticalsRats, Sprague-DawleyReceptors, Dopamine D2Receptors, Dopamine D3SpiperoneDopamine D2 Receptor AntagonistsRacloprideRadiopharmaceuticalsReceptors, Dopamine D2Receptors, Dopamine D3SpiperoneTritium[(3)H]PhNO[(3)H]Raclopride[(3)H]SpiperoneD(2/3) receptorInternalisationPET

Identifiers

PMID24910074
PMCPMC4109028
OpenAlexW2081654913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.